These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 22801295
1. 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors. Eriksson TM, Holst S, Stan TL, Hager T, Sjögren B, Ogren SÖ, Svenningsson P, Stiedl O. Neuropharmacology; 2012 Nov; 63(6):1150-60. PubMed ID: 22801295 [Abstract] [Full Text] [Related]
2. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors. Zhang J, Huang XY, Ye ML, Luo CX, Wu HY, Hu Y, Zhou QG, Wu DL, Zhu LJ, Zhu DY. J Neurosci; 2010 Feb 17; 30(7):2433-41. PubMed ID: 20164327 [Abstract] [Full Text] [Related]
3. Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice. Stiedl O, Misane I, Spiess J, Ogren SO. J Neurosci; 2000 Nov 15; 20(22):8515-27. PubMed ID: 11069959 [Abstract] [Full Text] [Related]
4. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test. Zhang H, Wang W, Jiang Z, Shang J, Zhang L. Arzneimittelforschung; 2010 Nov 15; 60(3):109-15. PubMed ID: 20422941 [Abstract] [Full Text] [Related]
5. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR. Eur Neuropsychopharmacol; 2004 Dec 15; 14(6):487-95. PubMed ID: 15589388 [Abstract] [Full Text] [Related]
6. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission. Costa L, Trovato C, Musumeci SA, Catania MV, Ciranna L. Hippocampus; 2012 Apr 15; 22(4):790-801. PubMed ID: 21538661 [Abstract] [Full Text] [Related]
7. 5-HT(1A) and NMDA receptors interact in the rat medial septum and modulate hippocampal-dependent spatial learning. Elvander-Tottie E, Eriksson TM, Sandin J, Ogren SO. Hippocampus; 2009 Dec 15; 19(12):1187-98. PubMed ID: 19309036 [Abstract] [Full Text] [Related]
8. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis. Stewart A, Maity B, Wunsch AM, Meng F, Wu Q, Wemmie JA, Fisher RA. FASEB J; 2014 Apr 15; 28(4):1735-44. PubMed ID: 24421401 [Abstract] [Full Text] [Related]
9. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors. Barton CL, Hutson PH. Synapse; 1999 Jan 15; 31(1):13-9. PubMed ID: 10025679 [Abstract] [Full Text] [Related]
10. Cross state-dependency of learning between 5-HT1A and/or 5-HT7 receptor agonists and muscimol in the mouse dorsal hippocampus. Jafari-Sabet M, Nemati S, Torab M. J Psychopharmacol; 2019 Jun 15; 33(6):722-736. PubMed ID: 30789290 [Abstract] [Full Text] [Related]
11. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors. Orús L, Pérez-Silanes S, Oficialdegui AM, Martínez-Esparza J, Del Castillo JC, Mourelle M, Langer T, Guccione S, Donzella G, Krovat EM, Poptodorov K, Lasheras B, Ballaz S, Hervías I, Tordera R, Del Río J, Monge A. J Med Chem; 2002 Sep 12; 45(19):4128-39. PubMed ID: 12213056 [Abstract] [Full Text] [Related]
12. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability. Zazpe A, Artaiz I, Labeaga L, Lucero ML, Orjales A. Neuropharmacology; 2007 Mar 12; 52(3):975-84. PubMed ID: 17141811 [Abstract] [Full Text] [Related]
13. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Pejchal T, Foley MA, Kosofsky BE, Waeber C. Br J Pharmacol; 2002 Mar 12; 135(5):1115-22. PubMed ID: 11877317 [Abstract] [Full Text] [Related]
14. 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. Eriksson TM, Golkar A, Ekström JC, Svenningsson P, Ogren SO. Eur J Pharmacol; 2008 Oct 31; 596(1-3):107-10. PubMed ID: 18789922 [Abstract] [Full Text] [Related]
15. 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor. Shelton J, Bonaventure P, Li X, Yun S, Lovenberg T, Dugovic C. Neuropharmacology; 2009 Feb 31; 56(2):448-54. PubMed ID: 18948124 [Abstract] [Full Text] [Related]
16. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist. Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I. J Pharmacol Exp Ther; 2002 Sep 31; 302(3):1220-7. PubMed ID: 12183683 [Abstract] [Full Text] [Related]
17. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition. Guptarak J, Sarkar J, Hiegel C, Uphouse L. Horm Behav; 2010 Jul 31; 58(2):290-6. PubMed ID: 20223238 [Abstract] [Full Text] [Related]
18. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. Knobelman DA, Hen R, Blendy JA, Lucki I. J Pharmacol Exp Ther; 2001 Sep 31; 298(3):1092-100. PubMed ID: 11504806 [Abstract] [Full Text] [Related]
19. HBK-14 and HBK-15 with antidepressant-like and/or memory-enhancing properties increase serotonin levels in the hippocampus after chronic treatment in mice. Pytka K, Gawlik K, Pawlica-Gosiewska D, Witalis J, Waszkielewicz A. Metab Brain Dis; 2017 Apr 31; 32(2):547-556. PubMed ID: 27888375 [Abstract] [Full Text] [Related]
20. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine. Rasmussen K, Calligaro DO, Czachura JF, Dreshfield-Ahmad LJ, Evans DC, Hemrick-Luecke SK, Kallman MJ, Kendrick WT, Leander JD, Nelson DL, Overshiner CD, Wainscott DB, Wolff MC, Wong DT, Branchek TA, Zgombick JM, Xu YC. J Pharmacol Exp Ther; 2000 Aug 31; 294(2):688-700. PubMed ID: 10900249 [Abstract] [Full Text] [Related] Page: [Next] [New Search]